Navidea Biopharmaceuticals to Present at the Citi 2013 Global Healthcare Conference

Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that Dr. Mark Pykett, President and Chief Executive Officer, will participate at the Citi 2013 Global Healthcare Conference on February 25-27, 2013 at the Hilton New York Hotel in New York City. Dr. Pykett will provide an update of the Company and its development programs on Tuesday, February 26, 2013 at 11:05 AM EST.